Forearm brachial artery to brachial vein looped arteriovenous grafts: A single center,single surgeon observational study

Abstract

Background:

Long-term hemodialysis (HD) treatment requires the establishment of a cannulatable vascular access (VA) point. While the arteriovenous fistula (AVF) is considered the gold standard, the arteriovenous graft (AVG) is a viable alternative especially in patients with poor superficial venous anatomy. Few studies have assessed the efficacy of the brachial-brachial arteriovenous graft (BB-AVG) for long-term HD access. By analyzing one surgeon’s experience in creating, surveilling and maintaining BB-AVGs, this retrospective study aims to add to the body of literature in assessing patency outcomes of BB-AVGs.

Methods:

We identified 57 BB-AVGs that met inclusion criteria and were created between October 6, 2005 and May 1, 2019 by a single surgeon in 54 patients. We analyzed primary failures, patency, complications and interventions. Patency rates were calculated by the Kaplan–Meier method. The incidence of complications and interventions were expressed as number of events per person-year.

Results:

A total of 54 patients (median age of 65 years) were analyzed. Primary patency rates at 12, 24, and 36 months were 20.4% 7.4%, and 5.0%. Primary assisted patency rates at 12, 24, and 36 months were 46.7%, 33.5%, and 15.1%. The secondary patency rates at 12, 24, and 36 months were 81.8%, 63.8%, and 60.1%, respectively. The incidence of complications and interventions was 2.164 per person-year. Most complications and interventions were due to stenosis (1.202 per person-year) or thrombosis (0.802 per person-year).

Conclusion:

In patients with poor superficial veins, the brachial vein is a reasonable alternative to use as the venous outflow. However, in order to achieve acceptable patency rates, close monitoring of the VA, as well as aggressive treatment of complications within the brachial vein is necessary. Overall, the BB-AVG should be considered in patients who lack adequate superficial veins and require preservation of the more proximal veins.

Keywords

Dialysis AV fistula prosthetic grafts catheters brachial vein

Get full access to this article

View all access options for this article.

References

Howard

Goldstein

, et al. Fistula First Breakthrough Initiative (FFBI): lessons about arteriovenous fistula prevalence goals. Am J Kidney Dis 2013; 61(3): 523–525.

Vascular Access 2006 Work Group. Clinical practice guidelines for vascular access. Am J Kidney Dis 2006; 48(Suppl. 1): S176–S247.

Perera

Mueller

Kubaska

, et al. Superiority of autogenous arteriovenous hemodialysis access: maintenance of function with fewer secondary interventions. Ann Vasc Surg 2004; 18: 66–73.

Gibson

Gillen

Caps

, et al. Vascular access survival and incidence of revisions: a comparison of prosthetic grafts, simple autogenous fistulas, and venous transposition fistulas from the United States Renal Data System Dialysis Morbidity and Mortality Study. J Vasc Surg 2001; 34: 694–700.

Lok

Huber

Lee

, et al. KDOQI clinical practice guideline for vascular access: 2019 update. Am J Kidney Dis 2020; 75(4 Suppl. 2): S1–S164.

Pham

Kim

Ihenachor

, et al. A comparison of brachial artery-brachial vein arteriovenous fistulas with arteriovenous grafts in patients with poor superficial venous anatomy. J Vasc Surg 2017; 65(2): 444–451.

Fumgalli

Trovato

Migliori

, et al. The forearm arteriovenous graft between the brachial artery and the brachial vein as a reliable dialysis vascular access for patients with inadequate superficial veins. J. Vasc Surg 2019; 70(1): 199–207.e4.

Won

Min

Jang

, et al. Early result of arteriovenous graft with deep forearm veins as an outflow in hemodialysis patients. Ann Vasc Surg 2002; 16: 501–504.

Sidawy

Gray

Besarab

, et al. Recommended standards for reports dealing with arteriovenous hemodialysis accesses. J Vasc Surg 2002; 35: 603–610.

10.

Lee

Mokrzycki

Moist

, et al. Standardized definitions for hemodialysis vascular access. Semin Dial 2011; 24(5): 515–524.

11.

Angle

Chandra

The two-stage brachial artery-brachial vein autogenous fistula for hemodialysis: an alternative autogenous option for hemodialysis access. J Vasc Surg 2005; 42: 806–810.

12.

Casey

Tonnessen

Mannava

, et al. Brachial versus basilic vein dialysis fistulas: a comparison of maturation and patency rates. J Vasc Surg 2008; 47: 402–406.

13.

Dorobantu

Iliescu

Stiru

, et al. The brachio-brachial arteriovenous fistula: mid-term results. J Vasc Access 2010; 11(1): 23–25.

14.

Elwakeel

Saad

Elkiran

, et al. Unusual vascular access for hemodialysis: transposed venae comitante of the brachial artery. Ann Vasc Surg 2007; 21: 560–563.

15.

Greenberg

May

Suliman

, et al. The brachial artery-brachial vein fistula: expanding the possibilities for autogenous fistulae. J Vasc Surg 2008; 48: 1245–1250.

16.

Jennings

Sideman

Taubman

, et al. Brachial vein transposition arteriovenous fistulas for hemodialysis access. J Vasc Surg 2009; 50: 1121–1126.

17.

Karam

Rawa

Shoenfeld

, et al. Brachial vein transposition is a promising ultimate upper limb autologous arteriovenous angioaccess despite its many pitfalls. J Vasc Surg 2018; 67: 236–243.

18.

Lioupis

Mistry

Chandak

, et al. Autogenous brachial-brachial fistula for vein access. Haemodynamic factors predicting outcome and 1-year clinical data. Eur J Vasc Endovasc Surg 2009; 38: 770–776.

19.

Lioupis

Mistry

Rix

, et al. Comparison among transposed brachiobasilic, brachiobrachial arteriovenous fistulas and Flixene vascular graft. J Vasc Access 2011; 12: 36–44.

20.

Morale

Patanè

Incardona

, et al. Venae comitantes as a potential vascular resource to create native arteriovenous fistulae. J Vasc Access 2011; 12: 211–214.

21.

Sha

Luk

Tee

, et al. Our experience in using the brachial venae comitantes as a native vascular access for hemodialysis. Hemodial Int 2016; 20: 293–297.

22.

Srinivasaiah

Yalamuri

Umez-Eronini

, et al. Venae comitantes fistulae: an option in patients with difficult hemodialysis access. J Vasc Access 2007; 8(4): 258–261.

23.

Torina

Westheimer

Schanzer

HR.

Brachial vein transposition arteriovenous fistula: is it an acceptable option for chronic dialysis vascular access?

J Vasc Access 2008; 9: 39–44.

24.

Urayama

Clinical study of brachial vein transposition fistulas for hemodialysis. Japan J Cardiovasc Surg 2012; 41: 67–69.

25.

Chue

Thant

Luo

, et al. Comprehensive comparison of the performance of autogenous brachial-basilic transposition arteriovenous fistula and prosthetic forearm loop arteriovenous graft in a multiethnic Asian hemodialysis population. Biomed Res Int 2016; 2016: 8693278.

26.

Drouven

de Bruin

van Roon

, et al. Outcomes of basilic vein transposition versus polytetrafluoroethylene forearm loop graft as tertiary vascular access. J Vasc Surg 2019; 69(4): 1180–1186.

27.

Itoga

Virgin-Downy

Mell

MW.

Forearm loop arteriovenous grafts preserve and may create new upper arm access sites. J Vasc Access 2019; 20(6): 691–696.

28.

Keuter

De Smet

Kessels

, et al. A randomized multicenter study of the outcome of brachial-basilic arteriovenous fistula and prosthetic brachial-antecubital forearm loop as vascular access for hemodialysis. J Vasc Surg 2008; 47: 395–401.

29.

Rooijens

Burgmans

, et al. Autogenous radial-cephalic or prosthetic brachial-antecubital forearm loop AVF in patients with compromised vessels? A randomized, multicenter study of the patency of primary hemodialysis access. J Vasc Surg. 2005; 42(3): 481–486; discussions 487.

30.

Suemitsu

Iida

Shiraki

, et al. Predicting loss of patency after forearm loop arteriovenous graft. J Vasc Surg 2016; 64(2): 395–401.

31.

Almasri

Alsawas

Mainou

, et al. Outcomes of vascular access for hemodialysis: a systematic review and meta-analysis. J Vasc Surg 2016; 64: 236–243.